Add Company
Join Now

Elixiron Immunotherapeutics Revenue and Competitors

License our Company Data API

Taipei,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Elixiron Immunotherapeutics's estimated annual revenue is currently $3.3M per year.(i)
  • Elixiron Immunotherapeutics's estimated revenue per employee is $155,000

Employee Data

  • Elixiron Immunotherapeutics has 21 Employees.(i)
  • Elixiron Immunotherapeutics grew their employee count by -9% last year.

Elixiron Immunotherapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Elixiron Immunotherapeutics?

Elixiron employs advances in translational medicine to identify targets from clinical observations, and various drug modalities including biologics derived from a proprietary single human B cell cloning platform to develop innovative therapies for malignant, immunological and degenerative diseases. Our lead pipeline candidates are EI-1071, a small molecule inhibitor of CSF1R kinase activity being explored as a potential therapy for Alzheimer's disease and to improve cancer immunotherapy by reducing immune suppression in tumors, and EI-001, a monoclonal antibody being investigated for treatment of chronic Hepatitis B and Vitiligo.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$3.3M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M2519%N/A
#2
$2.4M2613%N/A
#3
$4.3M28-12%N/A
#4
$8.1M294%N/A
#5
$4.3M2912%N/A